Goldman Sachs
TFFP

Goldman Sachs’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

Goldman Sachs’s Portfolio TFFP Stock Details TFFP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-534
Closed -$118K – 6975
2021
Q4 		$118K Buy
+534
New +$103K ﹤0.01% 6089
2021
Q2 		– Sell
-558
Closed -$189K – 6579
2021
Q1 		$189K Buy
+558
New +$227K ﹤0.01% 5669
2020
Q1 		– Sell
-635
Closed -$85K – 5619
2019
Q4 		$85K Buy
+635
New +$81.5K ﹤0.01% 5069

Other funds holding TFFP

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
PCM
Princeton Capital Management Red Bank, New Jersey $367M AUM 45.24% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Goldman Sachs's TFFP Position: Q1 2022 in Review

Goldman Sachs sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q1 2022, closing a stake of 534 shares — an estimated $118K sold.

Goldman Sachs first reported a position in TFFP in Q4 2019 and held it in 3 quarters. The position peaked at $189K in Q1 2021. 43 funds tracked by Wall St. Rank hold TFFP as of Q1 2022.

  • Goldman Sachs reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Goldman Sachs sold 534 TFF Pharmaceuticals, Inc. Common Stock shares in Q1 2022, an estimated $118K.
  • Goldman Sachs first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 3 quarters.
  • Goldman Sachs's TFF Pharmaceuticals, Inc. Common Stock position peaked at $189K in Q1 2021.
  • 43 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q1 2022.

Based on Goldman Sachs's 13F filing for Q1 2022, filed 16 May 2022.